Health and Me

Rachel V Thomas

Trump Strikes Drug Pricing Deals With 9 More Drug makers: Will Americans Finally Pay Less For Medicines?

Trump Strikes Drug Pricing Deals With 9 More Drugmakers: Will Americans Finally Pay Less For Medicines?

US President <span>Donald Trump</span> has announced drug pricing deals with nine more drug makers, including international pharmaceutical companies and smaller biotech firms, as part of his push to make healthcare more affordable.

Currently, US consumers pay nearly three times more for prescription medicines than people in other developed nations. <span>Trump</span> has been pressuring drug makers to bring the prices closer to those paid in other countries.

The latest deals, the <span>White House</span> said in a statement, bring the administration’s total to 26 drug makers. According to Trump, these represent 90% of the domestic pharmaceutical market, while the remaining 10% is “also coming in” and “have no choice.”

<h2>Which Companies Signed the Deals?</h2>

The latest agreements build on the administration’s broader “most favored nation” (<span>MFN</span>) drug pricing policy.

The White House said the nine companies are:

<ul><li>Alcon</li><li>Astellas Pharma</li><li>BeOne Medicines</li><li>BridgeBio</li><li>CSL</li><li>Kyowa Kirin</li><li>Sun Pharma</li><li>Teva Pharmaceuticals</li><li>UCB</li></ul>

The White House said the agreements will lower prices on medicines used to treat costly chronic and rare diseases, including hemophilia, Parkinson’s disease, macular degeneration, glaucoma, liver disease, skin conditions and various cancers.

The deals give every state <span>Medicaid</span> program access to MFN prices on products from the nine companies, generating billions of dollars in savings.

The agreements also guarantee MFN pricing for all new innovative medicines the companies bring to market, which the administration says will prevent foreign price controls from benefiting from US pharmaceutical innovation.

<h2>$19.6 Billion US Manufacturing Investment</h2>

The nine companies have committed to investing at least $19.6 billion collectively in US manufacturing in the near term, according to the White House.

Astellas, Sun Pharma, Teva and UCB also agreed to donate active pharmaceutical ingredients to the federal government’s strategic reserve, known as SAPIR, aimed at reducing reliance on foreign supplies and preparing for emergencies.

Over the past year, the administration reached deals with 17 other drug makers, including Pfizer, <span>Eli Lilly</span> and <span>Novo Nordisk</span>.

Novo Nordisk and Eli Lilly reportedly agreed to price cuts in exchange for making their medicines more widely available through Medicare.

Trump also signed an executive order in May 2025 to revive the MFN policy, calling for prices to be increased outside the US and to “end global freeloading.”

The biggest savings from earlier drug pricing deals have come from weight-loss medicines.

It remains unclear how many medicines are covered by the new deals or how large the discounts will be, making the potential savings for patients and the government difficult to determine.

The White House did not release details of the agreements, while some companies described certain terms as private. The administration and several companies said the deals will also bring future savings on innovative medicines and expand US manufacturing.

Beyond weight-loss drugs, consumer watchdog Public Citizen has questioned how much price relief Americans are actually receiving from the administration’s agreements, Reuters reported.

Medicaid already receives steep discounts from drug makers under existing law, while most Medicaid beneficiaries pay little out of pocket for prescriptions.

Health Conditions A-Z

health

trump-strikes-drug-pricing-deals-with-9-more-drugmakers-will-americans-finally-pay-less-for-medicines

trump

novo nordisk

white house

medicaid

eli lilly

donald trump

Trump Strikes Drug Pricing Deals

indias-superbug-crisis-icmr-study-finds-drug-resistant-infections-have-become-harder-costlier-to-treat

Nearly 1 In 2 Patients Die, Treatment Costs Rise By 46%: ICMR Study Reveals Impact Of Drug-Resistant Infections

why-new-cdc-director-has-challenged-report-of-two-measles-deaths-in-pennsylvania

Why Has CDC Challenged The Report Of Two Measles Deaths In Pennsylvania?

Health News

8 Sit-Up Variations to Strengthen Your Core and Build Stability

Benefits Of Ayurvedic Health Supplement Ashwagandha

9 Anti-Inflammatory Breakfast Options You Should Try

5 Foods You Should Avoid For PCOS, Says Gynecologist

Love Sitting With Your Legs Crossed? Here’s You Should Avoid It

6 Daily Foods That Are Secretly Increasing Your Calories

9 Brain Boosters You Should Do Everyday

Hip Exercises That Will Keep You Flexible As You Age

9 Leg Exercises Office Workers’ Should Do At Home

Benefits of Having Herbal Tea Every Morning

9 Daily Habits That Boost Your Brain Power

Lower-Body Exercises That Are Game-Changers

How Drinking Apple Cider Vinegar Helps You

Aging Myths You Should Never Believe

Superfoods That Support Your Gut Health

What Happens To Your Body When You Eat Instant Noodles Every Day?

Health Issues Premature Babies Often Face

Exercises Office Workers Should Do For Their Heart Health

Reasons Why You Should Add Raw Turmeric To Your Diet

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

US President Donald Trump has announced drug pricing deals with nine more drug makers, including international pharmaceutical companies and smaller biotech firms, as part of his push to make healthcare more affordable.Currently, US consumers pay nearly three times more for prescription medicines than people in other developed nations. Trump has been pressuring drug makers to bring the prices closer to those paid in other countries.The latest deals, the White House said in a statement, bring the administration’s total to 26 drug makers. According to Trump, these represent 90% of the domestic pharmaceutical market, while the remaining 10% is “also coming in” and “have no choice.”Which Companies Signed the Deals?The latest agreements build on the administration’s broader “most favored nation” (MFN) drug pricing policy.The White House said the nine companies are:AlconAstellas PharmaBeOne MedicinesBridgeBioCSLKyowa KirinSun PharmaTeva PharmaceuticalsUCBWhat Do the Deals Mean?The White House said the agreements will lower prices on medicines used to treat costly chronic and rare diseases, including hemophilia, Parkinson’s disease, macular degeneration, glaucoma, liver disease, skin conditions and various cancers.The deals give every state Medicaid program access to MFN prices on products from the nine companies, generating billions of dollars in savings.The agreements also guarantee MFN pricing for all new innovative medicines the companies bring to market, which the administration says will prevent foreign price controls from benefiting from US pharmaceutical innovation.$19.6 Billion US Manufacturing InvestmentThe nine companies have committed to investing at least $19.6 billion collectively in US manufacturing in the near term, according to the White House.Astellas, Sun Pharma, Teva and UCB also agreed to donate active pharmaceutical ingredients to the federal government’s strategic reserve, known as SAPIR, aimed at reducing reliance on foreign supplies and preparing for emergencies.Previous Drug Pricing DealsOver the past year, the administration reached deals with 17 other drug makers, including Pfizer, Eli Lilly and Novo Nordisk.Novo Nordisk and Eli Lilly reportedly agreed to price cuts in exchange for making their medicines more widely available through Medicare.Trump also signed an executive order in May 2025 to revive the MFN policy, calling for prices to be increased outside the US and to “end global freeloading.”The biggest savings from earlier drug pricing deals have come from weight-loss medicines.Novo Nordisk and Eli Lilly reportedly agreed to price cuts in exchange for making their medicines more widely available through Medicare.Will Americans Pay Less?It remains unclear how many medicines are covered by the new deals or how large the discounts will be, making the potential savings for patients and the government difficult to determine.The White House did not release details of the agreements, while some companies described certain terms as private. The administration and several companies said the deals will also bring future savings on innovative medicines and expand US manufacturing.Beyond weight-loss drugs, consumer watchdog Public Citizen has questioned how much price relief Americans are actually receiving from the administration’s agreements, Reuters reported.Medicaid already receives steep discounts from drug makers under existing law, while most Medicaid beneficiaries pay little out of pocket for prescriptions.

trump strikes drug pricing deals with 9 more drug makers: will americans finally pay less for medicines?

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

Trump Strikes Drug Pricing Deals With 9 More Drug makers: Will Americans Finally Pay Less For Medicines?

Nearly 1 In 2 Patients Die, Treatment Costs Rise By 46%: ICMR Study Reveals Impact Of Drug-Resistant Infections

Why Has CDC Challenged The Report Of Two Measles Deaths In Pennsylvania?

Ebola Cases Cross 6,000, Death Toll Nears 3,000 In Congo; Mortality Rate Remains Close To 50%

Health Conditions A-Z

Trump Strikes Drug Pricing Deals With 9 More Drug makers: Will Americans Finally Pay Less For Medicines?

Nearly 1 In 2 Patients Die, Treatment Costs Rise By 46%: ICMR Study Reveals Impact Of Drug-Resistant Infections

Why Has CDC Challenged The Report Of Two Measles Deaths In Pennsylvania?